Neurobiology of Aging
Volume 32, Issue 12 , Pages 2131-2141 , December 2011

Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders

  • Lidia Glodzik

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 263 5698; fax: +1 212 263 3270.
    • ,
  • Susan de Santi

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • MedAvante Inc, Hamilton, NJ 08619, United States
    • ,
  • Wai Hon Tsui

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • Nathan Kline Institute, 140 Old Orangeburg Rd, Orangeburg, NY 10962, United States
    • ,
  • Lisa Mosconi

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • ,
  • Raymond Zinkowski

      Affiliations

    • Applied NeuroSolutions, 50 Lakeview Pkwy, Vernon Hills, IL 60061, United States
    • ,
  • Elizabeth Pirraglia

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • ,
  • Hui Yu Wang

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • QiLu Hospital, Shandong University, China
    • ,
  • Yi Li

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • ,
  • Kenneth E. Rich

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • ,
  • Henrik Zetterberg

      Affiliations

    • Department of Psychiatry and Neurochemistry, University of Goteborg, Sahlgrenska University Hospital, Sweden
    • ,
  • Kaj Blennow

      Affiliations

    • Department of Psychiatry and Neurochemistry, University of Goteborg, Sahlgrenska University Hospital, Sweden
    • ,
  • Pankaj Mehta

      Affiliations

    • Institute for Basic Research, 1050 Forest Hill Road, Staten Island, NY 10314, United States
    • ,
  • Mony J. de Leon

      Affiliations

    • Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th floor, New York, NY 10016, United States
    • Nathan Kline Institute, 140 Old Orangeburg Rd, Orangeburg, NY 10962, United States
    • Corresponding Author InformationCorresponding author at: Center for Brain Health, Center of Excellence on Aging, Department of Psychiatry, NYU School of Medicine, 145 East 32nd Street, New York, NY 10016, United States. Tel.: +1 212 263 5805; fax: +1 212 263 3270.

Received 29 July 2009 ,Revised 20 November 2009 ,Accepted 21 December 2009.

References 

  1. Ashburner J, Friston KJ. Voxel-based morphometry—the methods. Neuroimage. 2000;11:805–821
  2. Bennet DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer's disease pathology and cerebral infarctions. Neurology. 2005;64:834–841
  3. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet Neurol. 2006;368:387–403
  4. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol. Chem. Neuropathol. 1995;26:231–245
  5. Boyle PA, Wilson RS, Aggarwal NT, Tang Y, Bennett DA. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006;67:441–445
  6. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259
  7. Brett M, Anton JC, Valabregue R, Poline J-B. Region of interest analysis using an SPM toolbox. In: Neuroimage 16: pp 8th International Conference on Functional Mapping of the Human Brain, June 2–6, 2002. Sendai, Japan. 2002;
  8. Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, et al. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol. Aging. 2009;30:682–690
  9. De Santi S, Pirraglia E, Barr WB, Babb J, Williams S, Rogers K, et al. Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology. 2008;22:469–484
  10. Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, et al. Decreased cerebrospinal fluid A42 correlates with brain atrophy in cognitively normal elderly. Ann. Neurol. 2009;65:176–183
  11. Fagan AM, Roe CM, Xiong C, Mintun M, Morris JC, Holtzman DM. Cerebrospinal fluid tau/beta-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 2007;64:343–349
  12. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68:288–291
  13. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JCS, et al. Incidence and prevalence of dementia in the cardiovascular health study. JAGS. 2004;52:195–204
  14. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 1975;12:189–198
  15. Freeborough PA, Woods RP, Fox NC. Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. J. Comput. Assist. Tomogr. 1996;20:1012–1022
  16. Gilbert JG. Guild Memory Test Manual. Newark, NJ: UNICO National Mental Health Research Center; 1970;
  17. Glodzik-Sobanska L, Rusinek H, Mosconi L, Li Y, Zhan J, De Santi S, et al. The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease. Neuroimag. Clin. N. Am. 2005;15:803–826
  18. Golomb J, de Leon MJ, Kluger A, George AE, Tarshish C, Ferris SH. Hippocampal atrophy in normal aging an association with recent memory impairment. Arch. Neurol. 1993;50:967–973
  19. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage. 2002;17:29–46
  20. Gustafson DR, Skoog I, Rosengren L, Zetterberg H, Blennow K. Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women. J. Neurol. Neurosurg. Psychiatry. 2006;78:461–464
  21. Jessen F, Feyen L, Freymann K, Tepest R, Maier W, Heun R, et al. Volume reduction of the entorhinal cortex in subjective memory impairment. Neurobiol. Aging. 2006;27:1751–1756
  22. Kluger A, Ferris SH, Golomb J, Mittelman MS, Reisberg B. Neuropsychological prediction of decline to dementia in nondemented elderly. J. Geriat. Psychiatry Neurol. 1999;12:168–179
  23. Kohnken R, Buerger K, Zinkowski R, Miller C, Kerkman D, DeBernardis J, et al. Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. Neurosci. Lett. 2000;287:187–190
  24. Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, et al. CSF tau/A{Beta}42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology. 2007;69:631–639
  25. Loew AD, Yanowsky I, Parikshak N, Hua X, Lee S, Toga AW, et al. Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage. 2009;45:645–655
  26. Mehta PD, Pirttila T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol. 2000;57:100–105
  27. Mortimer JA, Gosche KM, Riley KP, Markesbery WR, Snowdon DA. Delayed recall hippocampal volume and Alzheimer neuropathology. Findings from the Nun Study. Neurology. 2004;62:428–432
  28. NIH Publication No. 02-5125, 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). Final Report. Circulation 106, p. 3143.
  29. Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG. Memory function in very early Alzheimer's disease. Neurology. 1994;44:867–872
  30. Reisberg B, London E, Ferris SH, Borenstein J, Scheier L, de Leon MJ. The brief cognitive rating scale: language motoric, and mood concomitants in primary degenerative dementia. Psychopharmacol. Bull. 1983;19:702–708
  31. Reisberg B, Sclan SG, Franssen EH, de Leon MJ, Kluger A, Torossian CL, et al. Clinical stages of normal aging and Alzheimer's disease: the GDS staging system. Neurosci. Res. Commun. 1993;13(Suppl. 1):551–554
  32. Rusinek H, De Santi S, Frid D, Tsui W, Tarshish C, Convit A, et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology. 2003;229:691–696
  33. Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, et al. Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology. 2004;63:2354–2359
  34. Saykin AJ, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, et al. Older adults with cognitive complaints show brain atrophy simialr to that of amnestic MCI. Neurology. 2006;67:834–842
  35. Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, et al. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology. 2003;61:487–492
  36. Skoog I, Davidsson P, Aevarsson O, Vanderstichele H, Vanmechelen E, Blennow K. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds. Demen. Geriatr. Cogn. Disord. 2003;15:169–176
  37. Sluimer, J, Bouwman, F.H., Vrenken, H., Blankenstein, M.A., Barkhof, F., van der Flier, W. M., Scheltens, P., 2008. Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study. Neurobiol. Aging, in press, 10.1016/j.neurobiolaging.2008.06.016. [Epub ahead of print].
  38. Stomrud E, Hansson O, Blennow K, Minthon L, Londos E. Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly. Demen. Geriatr. Cogn. Disord. 2007;24:118–124
  39. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme; 1988;
  40. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, et al. MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. on behalf of the Alzheimer's Diasese Neuroimaging Initiative Neurology. 2009;73:287–293
  41. Wechsler D. Wechsler Adult Intelligence Scale—Revised. New York: Harcourt Brace Jovanovich; 1981;
  42. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch. Neurol. 1991;48:278–281
  43. Wiltfang J, Esselmann H, Bibl M, Hull M, Hampel H, Kessler H, et al. Amyloid beta peptide ratio 42/40 but not A Beta 42 correlates with phospho-tau in patients with low- and high-CSF A Beta 40 load. J. Neurochem. 2007;101:1053–1059
  44. Zehnder AE, Blasi S, Berres M, Speigel R, Monsch AU. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?. Am. J. Alzheimer's Dis. Other Demen. 2007;22:416–426

PII: S0197-4580(10)00011-4

doi: 10.1016/j.neurobiolaging.2009.12.026

Neurobiology of Aging
Volume 32, Issue 12 , Pages 2131-2141 , December 2011

Article Tools

* Image Usage & Resolution